These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 31150957)

  • 41. Comparison of brain connectomes by MRI and genomics and its implication in Alzheimer's disease.
    Woo YJ; Roussos P; Haroutunian V; Katsel P; Gandy S; Schadt EE; Zhu J;
    BMC Med; 2020 Feb; 18(1):23. PubMed ID: 32024511
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
    Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
    Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Liu E; Morris JC; Petersen RC; Saykin AJ; Schmidt ME; Shaw L; Shen L; Siuciak JA; Soares H; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2013 Sep; 9(5):e111-94. PubMed ID: 23932184
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multi-modal neuroimaging feature selection with consistent metric constraint for diagnosis of Alzheimer's disease.
    Hao X; Bao Y; Guo Y; Yu M; Zhang D; Risacher SL; Saykin AJ; Yao X; Shen L;
    Med Image Anal; 2020 Feb; 60():101625. PubMed ID: 31841947
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.
    Ben Bouallègue F; Mariano-Goulart D; Payoux P;
    Alzheimers Res Ther; 2017 Apr; 9(1):32. PubMed ID: 28441967
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prediction of amyloid pathology in cognitively unimpaired individuals using voxel-wise analysis of longitudinal structural brain MRI.
    Petrone PM; Casamitjana A; Falcon C; Artigues M; Operto G; Cacciaglia R; Molinuevo JL; Vilaplana V; Gispert JD;
    Alzheimers Res Ther; 2019 Aug; 11(1):72. PubMed ID: 31421683
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detecting Amyloid Positivity Using Morphometric Magnetic Resonance Imaging.
    Pereira HR; Diogo VS; Prata D; Ferreira HA;
    J Alzheimers Dis; 2024; 101(4):1293-1305. PubMed ID: 39331101
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predicting mild cognitive impairment progression to Alzheimer's disease based on machine learning analysis of cortical morphological features.
    Wang W; Peng J; Hou J; Yuan Z; Xie W; Mao G; Pan Y; Shao Y; Shu Z
    Aging Clin Exp Res; 2023 Aug; 35(8):1721-1730. PubMed ID: 37405620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structural, static, and dynamic functional MRI predictors for conversion from mild cognitive impairment to Alzheimer's disease: Inter-cohort validation of Shanghai Memory Study and ADNI.
    Chen Z; Chen K; Li Y; Geng D; Li X; Liang X; Lu H; Ding S; Xiao Z; Ma X; Zheng L; Ding D; Zhao Q; Yang L;
    Hum Brain Mapp; 2024 Jan; 45(1):e26529. PubMed ID: 37991144
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional connectivity of white matter as a biomarker of cognitive decline in Alzheimer's disease.
    Gao Y; Sengupta A; Li M; Zu Z; Rogers BP; Anderson AW; Ding Z; Gore JC;
    PLoS One; 2020; 15(10):e0240513. PubMed ID: 33064765
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predicting Alzheimer's progression in MCI: a DTI-based white matter network model.
    Song Q; Peng J; Shu Z; Xu Y; Shao Y; Yu W; Yu L
    BMC Med Imaging; 2024 May; 24(1):103. PubMed ID: 38702626
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predicting Prodromal Alzheimer's Disease in Subjects with Mild Cognitive Impairment Using Machine Learning Classification of Multimodal Multicenter Diffusion-Tensor and Magnetic Resonance Imaging Data.
    Dyrba M; Barkhof F; Fellgiebel A; Filippi M; Hausner L; Hauenstein K; Kirste T; Teipel SJ;
    J Neuroimaging; 2015; 25(5):738-47. PubMed ID: 25644739
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A "glympse" into neurodegeneration: Diffusion MRI and cerebrospinal fluid aquaporin-4 for the assessment of glymphatic system in Alzheimer's disease and other dementias.
    Sacchi L; D'Agata F; Campisi C; Arcaro M; Carandini T; Örzsik B; Dal Maschio VP; Fenoglio C; Pietroboni AM; Ghezzi L; Serpente M; Pintus M; Conte G; Triulzi F; Lopiano L; Galimberti D; Cercignani M; Bozzali M; Arighi A
    Hum Brain Mapp; 2024 Aug; 45(12):e26805. PubMed ID: 39185685
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cortical graph neural network for AD and MCI diagnosis and transfer learning across populations.
    Wee CY; Liu C; Lee A; Poh JS; Ji H; Qiu A;
    Neuroimage Clin; 2019; 23():101929. PubMed ID: 31491832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Determination of Alzheimer's disease based on morphology and atrophy using machine learning combined with automated segmentation.
    Ikemitsu N; Kanazawa Y; Haga A; Hayashi H; Matsumoto Y; Harada M
    Acta Radiol; 2024 Apr; 65(4):359-366. PubMed ID: 38196180
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    Peng J; Wang W; Song Q; Hou J; Jin H; Qin X; Yuan Z; Wei Y; Shu Z
    Acad Radiol; 2023 Sep; 30(9):1874-1884. PubMed ID: 36587998
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [
    Xue L; Fu Y; Gao X; Feng G; Qian S; Wei L; Li L; Zhuo C; Zhang H; Tian M
    Eur J Nucl Med Mol Imaging; 2024 Oct; 51(12):3617-3629. PubMed ID: 38839623
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Locally linear embedding (LLE) for MRI based Alzheimer's disease classification.
    Liu X; Tosun D; Weiner MW; Schuff N;
    Neuroimage; 2013 Dec; 83():148-57. PubMed ID: 23792982
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion.
    Westman E; Muehlboeck JS; Simmons A
    Neuroimage; 2012 Aug; 62(1):229-38. PubMed ID: 22580170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.